Department of Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia;
Department of Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia.
Hosp Pediatr. 2020 Dec;10(12):1096-1101. doi: 10.1542/hpeds.2020-0124. Epub 2020 Nov 9.
To determine the incidence of refeeding syndrome in otherwise healthy children <3 years of age admitted for failure to thrive (FTT).
A multicenter retrospective cohort study was performed on patients aged ≤36 months admitted with a primary diagnosis of FTT from January 1, 2011, to December 31, 2016. The primary outcome measure was the percentage of patients with laboratory evidence of refeeding syndrome. Exclusion criteria included admission to an ICU, parenteral nutrition, history of prematurity, gastrostomy tube feeds, and any complex chronic conditions.
Of the 179 patients meeting inclusion criteria, none had laboratory evidence of refeeding syndrome. Of these, 145 (81%) had laboratory work done at the time of admission, and 69 (39%) had laboratory work repeated after admission. A small percentage (6%) of included patients experienced an adverse event due to repeat laboratory draw.
In otherwise healthy hospitalized patients <3 years of age with a primary diagnosis of FTT, routine laboratory monitoring for electrolyte derangements did not reveal any cases of refeeding syndrome. More robust studies are needed to determine the safety and feasibility of applying low-risk guidelines to this patient population to reduce practice variability and eliminate unnecessary laboratory evaluation and monitoring.
确定因生长迟缓而入院的健康状况良好的 <3 岁儿童发生再喂养综合征的发生率。
对 2011 年 1 月 1 日至 2016 年 12 月 31 日期间因生长迟缓而入院、且诊断为原发性生长迟缓的 ≤36 月龄患者进行了一项多中心回顾性队列研究。主要观察指标为出现再喂养综合征实验室证据的患者比例。排除标准包括入住 ICU、肠外营养、早产史、胃造口管喂养和任何复杂的慢性疾病。
在符合纳入标准的 179 例患者中,均无再喂养综合征的实验室证据。其中,145 例(81%)在入院时进行了实验室检查,69 例(39%)在入院后重复进行了实验室检查。一小部分(6%)纳入的患者因重复进行实验室抽血而发生不良事件。
在因原发性生长迟缓而入院的健康状况良好的 <3 岁住院患儿中,常规电解质紊乱实验室监测并未发现任何再喂养综合征病例。需要进行更有力的研究,以确定将低风险指南应用于该患者人群的安全性和可行性,以减少实践中的变异性,并消除不必要的实验室评估和监测。